Home » Topics » BioWorld Science

BioWorld Science
RSS

Bristol Myers Squibb presents first-in-class NLRP3 receptor agonists

April 15, 2021

Moderna reports interim clinical data on RSV and CMV vaccine candidates

April 15, 2021

New target identified for treatment-resistant colorectal cancer

April 15, 2021

CDC7 inhibitor TQB-3824 shows promise in preclinical study

April 15, 2021

Promising results for triple A1/A2A/A2B adenosine receptor antagonist in cancer immunotherapy

April 15, 2021

Shenzhen Targetrx Biotechnology identifies mutant EGFR and HER2 inhibitors

April 15, 2021

Shanghai Sun-Sail Pharmaceutical Science & Technology patents antituberculosis compounds

April 15, 2021

New NLRP3 agonists identified at Sichuan Kelun-Biotech Biopharmaceutical

April 15, 2021

Thyroid hormone receptor beta agonists discovered at Sunshine Lake Pharma

April 15, 2021

Chungbuk National University, Cellgentek describe chimeric cytokine receptor compositions

April 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...